ZBTB7A and uterine cancer: However, tissue and cancer-grade specific effects might be observed, as a recently published study revealed that ZBTB7A was commonly deleted in late stage oesophageal, bladder, colorectal, lung, ovarian and uterine cancers (Liu et al., 2014).